OLIVOLA, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 2155
EU - Europa 127
AS - Asia 28
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2314
Nazione #
US - Stati Uniti d'America 2152
IE - Irlanda 39
SE - Svezia 25
CN - Cina 17
DE - Germania 15
IT - Italia 11
UA - Ucraina 11
RU - Federazione Russa 8
FR - Francia 7
GB - Regno Unito 6
KR - Corea 5
CA - Canada 3
CL - Cile 2
EU - Europa 2
FI - Finlandia 2
IN - India 2
AT - Austria 1
CH - Svizzera 1
HK - Hong Kong 1
JP - Giappone 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2314
Città #
Wilmington 794
Houston 628
Woodbridge 316
Fairfield 80
Chandler 72
Ashburn 42
Seattle 37
Dublin 35
Cambridge 28
Ann Arbor 27
Medford 25
Lawrence 12
Dearborn 10
Beijing 8
Rome 8
San Diego 8
Menlo Park 6
Jacksonville 5
Norwalk 4
Philadelphia 4
Creede 3
London 3
Palo Alto 3
Redwood City 3
Seoul 3
Falls Church 2
Nanjing 2
Santa Clara 2
Shenzhen 2
Toronto 2
Changsha 1
Etobicoke 1
Hefei 1
Kunming 1
Lausanne 1
Nagold 1
New York 1
Phoenix 1
Saint Petersburg 1
San Francisco 1
Shanghai 1
Tokyo 1
Verona 1
Wuhan 1
Totale 2188
Nome #
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 408
Catecholamine-based treatment in AD patients: expectations and delusions 353
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 312
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 292
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 254
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 248
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 237
Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies (Neurological Sciences, (2019), 40, 9, (1917-1923), 10.1007/s10072-019-03920-5) 112
Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies 81
Validation of the Italian version of the PSP Quality of Life questionnaire 30
An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease 26
Effects of prismatic lenses on lateral axial dystonia in Parkinson's disease: a pilot study 17
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 9
Totale 2379
Categoria #
all - tutte 3602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201838 0000 00 00 001919
2018/2019478 23191517 2031 2961 51727268
2019/2020811 62585270 6171 7071 88856063
2020/2021563 68697063 6263 6849 1212252
2021/2022137 15511 218 45 10152239
2022/2023167 1322816 1935 2015 17020
Totale 2379